Navigation Links
Aida Announces Completion of Anti-Cancer Drug Phase Two Testing
Date:11/28/2007

SANTA MONICA, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that the Company has successfully completed Phase II field testing of its anti-cancer drug, Rh-Apo2L. The product of over a decade of research, Rh-Apo2L is intended to be a new drug therapy using a recombinant protein produced by genetic engineering. The drug is designed as a highly-targeted therapy with direct function on cancer cells. Assuming successful completion of all testing phases and approval of the drug by China's State Food and Drug Administration (SFDA), Aida expects to have Rh-Apo2L on the market during the third quarter of 2008.

Phase 2 testing results thus far have shown strong efficacy in treating lung cancer (non-small cell), non-Hodgkins lymphoma, stomach cancer, pancreatic cancer and kidney cancer. Shanghai Qiaer, Aida's research subsidiary, has reduced the key cancer targets to the three main diseases which Rh-Apo2L has shown the most efficacy and which have the most market potential. These three cancer targets will be announced at a later date, pending successful trials. Formal results will also be released after clinical tests are completed. After that, the company will apply for the approval of commencement of Phase III clinical trials from SFDA.

About Aida Pharmaceuticals

Aida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China and ISO9002 certified for quality assurance and ISO14000 certified for ecologically-friendly practi
'/>"/>

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... ROCKVILLE, Md. , March 26, 2015  RegeneRx ... that it has received a patent acceptance notice from ... beta 4 (TB4) to prevent or reduce tissue damage ... often the case when cardiac vessels are opened after ... circumstances when treating stroke victims. Damage can ...
(Date:3/26/2015)... HEIGHTS, Mich. , March 26, 2015 InfuSystem ... infusion pumps and related services for the healthcare industry in ... Canada , announced today it has secured a new ... has retired its previous $36.5 million credit facility with its ... the Company entered into the new five-year senior secured credit ...
(Date:3/26/2015)... TAMPA, Fla. , March 26, 2015 ... owned subsidiary of Oxis International, Inc. [OTC: ... the execution of an exclusive option agreement ... certain patents/intellectual properties developed by Dr. ... Innovation and Professor, Pharmaceutical Sciences, School of ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3
... /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH ) ... marketer of orthopedic implants in China, today announced that the ... August 16, 2011, before the market opens. Kanghui ... August 16, 2011 to discuss second quarter results and answer ...
... ATLANTA, July 28, 2011 Data presented this week at ... many people have low vitamin D levels and that testing ... to published data from the Third National Health and Nutrition ... only 23 percent of Americans have vitamin D levels over ...
Cached Medicine Technology:China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 3
(Date:3/27/2015)... Smile Brands Inc. ( http://www.smilebrands.com ), one ... to dental groups in the United States, is announcing ... office in Hendersonville, TN. , Located at ... Castle Dental office provides families with a convenient, comfortable ... quality dental care. Hendersonville marks the eleventh Castle Dental ...
(Date:3/27/2015)... Hawkins, Pastor and Overseer at The House of Yahweh in ... is through the Laws of Peace written in the Holy ... article titled, “Yahweh’s Way-The Great Difference” focuses on the past ... the original biblical instructions has caused mass chaos worldwide. ... in the world is based on man-made laws that will ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... a Quaker-based, philanthropic, grant-making foundation committed to raising ... behavioral healthcare is delivered. , The Scattergood Foundation ... advance Behavioral Health Policy and Practice through the ... SoundsLikeIBS Program App is designed to guide ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Let’s not ... store. Fresh produce are today’s traffic magnets. Three out ... supermarket because of their produce department, according to a ... ever as people are looking to add more fruits ... Your Produce Manager® Day is April 2. As featured ...
(Date:3/26/2015)... Franklin, TN (PRWEB) March 26, 2015 ... http://www.healthclick.com . This website is dedicated to providing information ... therapy and occupation therapy community. As a leader ... North American Seminars provided over 200 live and online ... PT OT continuing Education Courses :, A Master Clinicians ...
Breaking Medicine News(10 mins):Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3
... many different accounts of the crucifixion of Jesus find ... antique sources generally lack descriptions of crucifixions, says Gunnar ... doctoral thesis on the topic. Encyclopaedias, monographs and ... Jesus had to endure on Golgotha in Jerusalem. There ...
... ... research.,Updated website shows, based on research, reasons for RSI and Carpal Tunnel Syndrome and how ... ... the patented, ergonomic HandShoe Mouse, have decided to give complete access to its ergonomic fundamental ...
... ... with Pilot Pen to create a line of new products showing support ... a nonprofit committed to providing direct financial assistance to uninsured and underserved ... of breast cancer. To show support Pilot Pen is launching 10 new ...
... discussing anomalies found in ,routine, MRIs, researchers say , ... anomalies are often detected in children who undergo "routine" ... help pediatricians handle these findings, a new study suggests. ... they want to share with parents about such findings ...
... ... Marketing, Inc. ( www.hivemindinc.com ), a new marketing “mashup” that integrates ... media marketing, announced today that the firm has been selected as ... in high-performance BioAnalytical instruments, software, and assays for basic biology and ...
... In the ... of cycling injuries and urges caution on the roads , ... (PRWEB) June 14, 2010 -- National Accident Helpline is urging cyclists and other ... an increasing number of people take to their bikes, often for the first time in months., ...
Cached Medicine News:Health News:What do we really know about the crucifixion of Jesus? 2Health News:Ergonomic HandShoe Mouse Publish Proof of Unique Difference with Competition 2Health News:Ergonomic HandShoe Mouse Publish Proof of Unique Difference with Competition 3Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 2Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 3Health News:Harmless Brain Abnormalities in Kids Pose Disclosure Dilemmas 2Health News:Molecular Devices Relaunches with HiveMind Marketing 2Health News:Molecular Devices Relaunches with HiveMind Marketing 3Health News:Molecular Devices Relaunches with HiveMind Marketing 4Health News:Break The Injury Cycle, Says National Accident Helpline 2
... The UVS800DDA Universal Vacuum Source is a ... Cold Trap and 4-headed, Oil-free Vacuum Pump. It ... chemistry use and abuse., Combines a ... single housing eliminating extra tubing connections. ...
... designed for a wide variety of laboratory applications. ... eliminates oil mist vapors because it doesn't consume ... less fuss., Quiet, efficient operation ... ETFE and PFA heads , Recommended ...
... several different two-stage, oil-sealed, rotary vane vacuum ... applications. Each pump comes complete with a ... and Oil Mist Filter (EMF-10). The GBORK ... ballast to keep the oil clean without ...
Produces vacuum pressures required for 96 well kits...
Medicine Products: